HT PARP in vivo Pharmacodynamic Assay II
Pharmacodynamic (PD) assays have recently been developed and employed early in the drug screening process to assess the ability of potential drug candidates to affect molecular targets. These assays have the advantages of performing molecular proof-of-concept investigations at an early stage such as phase 0 trials, and later can be used to stratify patients into treatment pools during any stage of clinical assessment.
In cancer drug development, a current molecular target of high interest is poly(ADP-ribose) polymerase (PARP), as it is intimately involved in DNA repair and the survival or death of cancer cells. Until now, measuring the effectiveness of PARP inhibitors in cell and tissue lysates has been difficult and time consuming due to a lack of refined immunological reagents in an optimized and quantitative assay. Traditional PARP assays require the transfection of damaged DNA into the cells of interest in order to measure endogenous PARP activity, an especially difficult step when assaying cells from tissues.
Trevigen addresses this problem with the release of the HT PARP in vivo Pharmacodynamic Assay II, which is a high throughput, Chemiluminescent, PAR ELISA assay kit that has been validated on human peripheral blood lymphocytes and also shown to work with normal and tumor tissue. This improved assay features:
• Pre-coated capture antibody plates.
• Broad linear dynamic range to 1,000 pg/ml.
• High signal to noise ratio.
• Detection sensitivity of 2 pg/ml of PAR.
The amount of PAR present correlates directly with the activity of the PARP enzyme in cell lysates. This assay is ideal for quantification of PAR in peripheral blood mononuclear cells, tissues and cultured cells.
Related Products from Trevigen include PARP and PARG assay and cellular differentiation kits, PARP enzymes and PARP antibodies. Visit www.trevigen.com or contact us at 1-800-873-8443 or firstname.lastname@example.org for more information.
Trevigen, Inc. is a rapidly growing biotechnology company focused on the development of products and technology for cancer research, emphasizing apoptosis, DNA damage and repair, and cancer cell function and behavior.
8405 Helgerman Court, Gaithersburg, MD 20877 USA
Voice: 1-800-TREVIGEN (1-800-873-8443) • 301-216-2800
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release HT PARP in vivo Pharmacodynamic Assay II here
News-ID: 119291 • Views: 3769
More Releases from Trevigen, Inc.
Trevigen Releases CultreCoat® Cell Adhesion Assays
Trevigen announces the release of seven new coated well assay kits for cell adhesion studies. A cell’s ability to adhere to extracellular matrix (ECM) proteins is a necessary precursor to cell invasion, and this process also modulates morphogenesis, wound healing, proliferation, differentiation, and survival. Researchers studying cancer cell behavior or developing cancer therapeutics study cell adhesion with various proteins, recognizing that manipulation of cell adhesion to the extracellular environment may
Trevigen Announces the First Standardized Comet Assay Electrophoresis System
The comet assay is the only direct method for the detection of DNA damage in cells. It is used in cancer research, in genotoxicity studies on environmental mutagens, and for screening compounds for cancer therapeutics. Based on single cell gel electrophoresis in a controlled pH environment, the assay allows the integrity of stained nuclear DNA to be examined and measured. Until now, a lack of standardization in electrophoresis equipment, control cells,
Trevigen Announces a Highly Sensitive, Fluorescent, One Hour PARP Inhibition Ass …
Poly(ADP-ribose) polymerase, through ribosylation of nuclear proteins, converts DNA Damage into intracellular signals that actuate either DNA repair or cell death. The development of inhibitors to PARP is of ever increasing interest in the drug discovery community since they can be used as modulators of DNA repair mediated resistance to cytotoxic cancer therapeutics. Until now, commercially available PARP assay kits required multiple steps and were time consuming. Trevigen overcomes these
Trevigen announces the release of Four New Assay Kits for 3-D Cell Proliferation
Many scientists are converting from growing cells in a traditional 2-D Monolayer on plastic surfaces with tissue culture medium to “3-D” Culture. In 3-D Culture, cells are grown in a microenvironment of specialized proteins which mimics in vivo conditions and allows the cells to organize into complex structures rather than uniform monolayers. Various types of cells require different specialized proteins for optimal growth conditions and these extracellular matrices can play
More Releases for PAR
Global Radar (PSR, SSR, PAR) Market Future Forecast 2020-2025
This report also researches and evaluates the impact of Covid-19 outbreak on the Radar (PSR, SSR, PAR) industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Radar (PSR, SSR, PAR) Maker and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.). Market Overview The Radar (PSR, SSR, PAR) Maker market report provides a detailed analysis of global market size, regional and
JOIN US FOR A VIRTUAL PAR-TEA
While on a visit to South Africa to visit TIAS ARMS grantees and children, Founder Joanne Baker was forced to stop her travels and was isolated for fourteen days as the Covid 19 pandemic raged. What promises to be a spell-binding segment of TIAS ARMS 11th Annual, now Virtual, Tea Party fundraising event, June 13, 2020 via Zoom, is Joanne's story relating her struggle to get back into the United
Global LED PAR Cans Market Insights, Forecast
This report presents the worldwide LED PAR Cans market size (value, production and consumption), splits the breakdown (data status 2013-2018 and forecast to 2025), by manufacturers, region, type and application. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis. Get sample copy of the report: https://www.marketdensity.com/contact?ref=Sample&reportid=60622 Table of Contents: Table of Contents 1 Study
Tuberculin Market 2017 - Sanofi Pasteur, Zoetis, Par Sterile, SSI
Apex Research, recently published a detailed market research study focused on the "Tuberculin Market" across the global, regional and country level. The report provides 360° analysis of "Tuberculin Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Tuberculin industry, and estimates the future trend of Tuberculin market on the basis of this
GREEN CREATIVE launches new PAR REFINE Series
SAN BRUNO, CA, July 21th, GREEN CREATIVE, the commercial grade LED lighting manufacturer proudly announces the launch of its latest generation of PAR lamps. The new award-winning PAR REFINE Series includes PAR38, PAR30 long and short neck and PAR20 lamp types in spot, narrow flood and flood beam angles. This year the IES selected the PAR REFINE Series for its 2017 Progress Report, and the PAR38 was chosen by Lighting for
Global PAR Light Market 2017 : PULSAR, Spotlight, Teclumen, Eurolite & Evolight
This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - LEDPRO - EVITON Lighting - PR Lighting - PROEL GROUP - PULSAR - Spotlight - Teclumen - TIMES SQUARE LIGHTING - A&O Lighting Technology The survey report by Market Research Store is an overview of the global PAR Light market. It covers all the recent trends including key developments in the global market in present and in future. Analyses